All samples were examined for AMR patterns through a minimum inhibitory concentration (MIC) - based automated system, the VITEK® 2 AST-GN80 test kit cards, and the VITEK® 2 COMPACT machine (bioMérieux) [20 (link), 21 (link)]. The MIC results were interpreted using an advanced Expert System™ based on the global Clinical and Laboratory Standards Institute and natural resistance guidelines, as in a previous study [7 (link)]. The following antimicrobial drugs were included in the VITEK® 2 AST-GN80 test: Benzylpenicillin, oxacillin, cefalotin (CEF), cefovecin (CEC), ceftiofur (CET), kanamycin (KAN), enrofloxacin (ENR), marbofloxacin (MAR), pradofloxacin, erythromycin, clindamycin (CLI), doxycycline, tetracycline (TCN), nitrofurantoin (NFT), chloramphenicol, and sulfamethoxazole/trimethoprim (SXT). Three AMR genes were re-examined, namely mecA, mecC, and blaZ [21 (link)–23 (link)]. Polymerase chain reaction (PCR) was performed with the primers used in a previous study [7 (link)]. Staphylococcal chromosomal cassette mec gene detection was performed through multiplex PCR [24 (link)].
Free full text: Click here